Pharmaceuticals Sector - Solvay
Pharmaceuticals Sector - Solvay
Pharmaceuticals Sector - Solvay
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Highlights<br />
January 2005<br />
<strong>Solvay</strong> fi nalizes<br />
the sale to BP of its<br />
interests in the BP<br />
<strong>Solvay</strong> Polyethylene<br />
joint ventures,<br />
concluding a series<br />
of transactions<br />
initiated by <strong>Solvay</strong><br />
and BP in 2000.<br />
April 2005<br />
<strong>Solvay</strong> Solexis begins<br />
marketing its new grade of<br />
TECNOFLON ®<br />
perfl uorinated elastomers,<br />
created by a brand-new<br />
polymerization technology<br />
able to generate products<br />
with unequalled properties.<br />
October 2005<br />
<strong>Solvay</strong> Pharma<br />
launches its project<br />
to integrate Fournier<br />
Pharma and create<br />
the future « <strong>Solvay</strong><br />
<strong>Pharmaceuticals</strong> ».<br />
February 2005<br />
The Rigid Plastic Foils activity,<br />
comprising the two Italian plants<br />
at Monfalcone and Fucine, is sold<br />
to Ineos.<br />
Vinythaï<br />
decides to integrate upstream<br />
in the PVM and VCM (vinyl<br />
chloride monomer) chain by doubling<br />
chlorine and ethylene dichloride<br />
production capacity at its Map<br />
Ta Phut plant (Thailand).<br />
July 2005<br />
<strong>Solvay</strong> agrees to sell its entire Industrial<br />
Foils activities – development,<br />
production and marketing of plastic fi lms<br />
and foils – to Renolit AG (Germany).<br />
<strong>Solvay</strong> concludes its major<br />
stategic acquisition of<br />
100%<br />
of Fournier Pharma.<br />
November 2005<br />
<strong>Solvay</strong> and Chemical Products<br />
Corporation (CPC) of the USA create a<br />
joint venture for their technical-grade<br />
barium and<br />
strontium<br />
carbonate<br />
activities.<br />
March 2005<br />
<strong>Solvay</strong> and<br />
Fournier<br />
Pharma’s<br />
shareholders<br />
sign agreement<br />
for <strong>Solvay</strong>’s<br />
acquisition of<br />
100% of<br />
Fournier Pharma.<br />
May 2005<br />
<strong>Solvay</strong> Solexis<br />
announces two major capacity<br />
expansions for ALGOFLON ® and<br />
HYFLON ® fl uorinated polymers<br />
at Spinetta Marengo (Italy).<br />
<strong>Solvay</strong> announces creation of a<br />
joint venture in China to produce<br />
ultra-pure hydrogen peroxide.<br />
August 2005<br />
<strong>Solvay</strong> Organics GmbH successfully<br />
concludes its public offer for chemical<br />
specialties company Girindus AG,<br />
operating out of Bensberg, Germany,<br />
with a site at Cincinnati, Ohio (USA),<br />
and creates a new<br />
“Molecular Solutions”<br />
Strategic Business Unit.<br />
2005 Highlights<br />
June 2005<br />
<strong>Solvay</strong> announces<br />
plant at Onsan<br />
(South Korea) to<br />
produce inorganic<br />
fl uorinated<br />
specialties for<br />
high-growth<br />
markets.<br />
September 2005<br />
<strong>Solvay</strong> creates a Technical Centre at<br />
Shanghai,<br />
China, in response to growing<br />
demand from Chinese customers<br />
for Specialty Polymers (<strong>Solvay</strong><br />
High Performance Materials R&D<br />
(Shanghai) Co., Ltd).<br />
December 2005<br />
<strong>Solvay</strong> and Gharda (India) sign an<br />
agreement for <strong>Solvay</strong> to acquire<br />
Gharda’s plastics division, providing<br />
access to very high performance<br />
PEEK polymers and<br />
additional polysulfone capacity.<br />
<strong>Solvay</strong> signs partnership<br />
agreement with BASF and Dow<br />
for production of hydrogen<br />
peroxide to supply propylene<br />
oxide production at Antwerp<br />
(Belgium).<br />
<strong>Solvay</strong> Global Annual Report 2005<br />
3